Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 2/20 | 0.53 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | MME | P08473 | 5/20 | 0.46 |
| ▸ | ACE | P12821 | 3/20 | 0.46 |
| ▸ | ECE1 | P42892 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | NPEPPS | P55786 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CPA1 | P15085 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL213626 | 1.00 | PTGS1 (0.53) | PTGS1GSTK1ALDH1A1MAPTLMNA | |
| SCHEMBL27574429 | 1.00 | PTGS1 (0.53) | PTGS1GSTK1ALDH1A1MAPTLMNA | |
| SCHEMBL11766266 | 1.00 | PTGS1 (0.53) | PTGS1GSTK1ALDH1A1MAPTLMNA | |
| SCHEMBL27922239 | 0.98 | PTGS1 (0.51) | PTGS1GSTK1ALDH1A1MAPTLMNA | |
| SCHEMBL27922237 | 0.98 | PTGS1 (0.51) | PTGS1GSTK1ALDH1A1MAPTLMNA | |
| SCHEMBL3393046 | 0.94 | ALDH1A1 (0.52) | PTGS1GSTK1ALDH1A1MAPTLMNA | |
| SCHEMBL3393040 | 0.94 | ALDH1A1 (0.52) | PTGS1GSTK1ALDH1A1MAPTLMNA | |
| Cysteine SCHEMBL6014792 | 0.94 | PTGS1 (0.61) | PTGS1GSTK1ALDH1A1MAPTLMNA | |
| Cysteine SCHEMBL6014796 | 0.94 | PTGS1 (0.61) | PTGS1GSTK1ALDH1A1MAPTLMNA | |
| Glycine SCHEMBL28155782 | 0.94 | PTGS1 (0.49) | PTGS1GSTK1ALDH1A1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1742 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595229-B2 | Method for producing derivative of organic substance and method for analyzing sample containing organic substance | AJINOMOTO CO., INC. (JP) | 2026-04-07 | — | — | US | claimed |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| US-20250336540-A1 | METABOLITE PREDICTORS FOR LUNG CANCER | JANSSEN PHARMACEUTICA NV (BE) | 2025-10-30 | — | — | US | claimed |
| US-20250334558-A1 | TOTAL HYDROGEN SULFIDE QUANTIFICATION | CLEVELAND CLINIC FOUND (US) | 2025-10-30 | — | — | US | claimed |
| US-20250269072-A1 | PROCESSES FOR PREPARING RADIOLABELLED CONJUGATES | CENTENARY INST OF CANCER MEDICINE AND CELL BIOLOGY (AU) | 2025-08-28 | — | — | US | claimed |
| EP-4598347-A1 | KITS AND USE THEREOF IN SURGICAL PROCEDURES FOR ENDOSCOPIC HARVESTING OF VESSELS | Marizyme, Inc. (US) | 2025-08-13 | — | — | EP | claimed |
| EP-4577190-A1 | ANTIOXIDANT-CONTAINING EYE DROP FORMULATIONS AND METHODS OF PREVENTION AND/OR TREATMENT USING SAME | Marizyme, Inc. (US) | 2025-07-02 | — | — | EP | claimed |
| US-12344871-B2 | Method for producing cysteine from glutathione | AMANO ENZYME INC. (JP) | 2025-07-01 | — | — | US | claimed |
| US-20250152494-A1 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | THE BOOTS COMPANY PLC (GB) | 2025-05-15 | — | — | US | claimed |
| CN-119969563-A | Method for preparing flavoring agent | 联合利华知识产权控股有限公司 | 2025-05-13 | — | — | CN | claimed |
| EP-0777472-A2 | METHODS FOR IDENTIFYING AND TREATING RESISTANT TUMORS | ELI LILLY AND COMPANY (US) | 1997-06-11 | — | — | EP | claimed |
| EP-0675712-A4 | REDUCTION OF HAIR GROWTH EMPLOYING SULFHYDRYL REACTIVE COMPOUNDS. | HANDELMAN JOSEPH H (US) | 1996-11-06 | — | — | EP | claimed |
| WO-1996006604-A2 | METHODS FOR IDENTIFYING AND TREATING RESISTANT TUMORS | ELI LILLY AND COMPANY (US) | 1996-03-07 | — | — | WO | claimed |
| EP-0675712-A1 | REDUCTION OF HAIR GROWTH EMPLOYING SULFHYDRYL REACTIVE COMPOUNDS | HANDELMAN, Joseph H. (US) | 1995-10-11 | — | — | EP | claimed |
| US-5411991-A | Applying to human skin, beards, reaction with cysteine | GILLETTE COMPANY, THE, A DELAWARE CORPORATION | 1995-05-02 | — | — | US | claimed |
| EP-0604433-A4 | COMPOSITION AND METHOD FOR DISEASE TREATMENT. | LIFE SCIENCES TECH INC (US) | 1994-10-12 | — | — | EP | claimed |
| WO-1994014428-A1 | REDUCTION OF HAIR GROWTH EMPLOYING SULFHYDRYL REACTIVE COMPOUNDS | HANDELMAN, JOSEPH, H. (US) | 1994-07-07 | — | — | WO | claimed |
| EP-0604433-A1 | COMPOSITION AND METHOD FOR DISEASE TREATMENT | LIFE SCIENCES' TECHNOLOGIES, INC. (US) | 1994-07-06 | — | — | EP | claimed |
| WO-1992021368-A1 | COMPOSITION AND METHOD FOR DISEASE TREATMENT | LIFE SCIENCES' TECHNOLOGIES, INC. (US) | 1992-12-10 | — | — | WO | claimed |
| WO-1990003666-A1 | STATE OF CHARGE OF REDOX CELL | UNISEARCH LIMITED (AU) | 1990-04-05 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250269072-A1 | PROCESSES FOR PREPARING RADIOLABELLED CONJUGATES | AS3MT, TP53, ANXA5 | PTGS1 4705/4885GSTK1 385/4885ALDH1A1 2153/4885 |
| US-12595229-B2 | Method for producing derivative of organic substance and method for analyzing sample containing organic substance | SULT1E1, CNR2, SRMS | PTGS1 759/4885GSTK1 1530/4885ALDH1A1 672/4885 |
| US-20250152494-A1 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | RARA, RARG, RARB | PTGS1 4533/4885GSTK1 1472/4885ALDH1A1 1732/4885 |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | GLS, AADAT, FGF23 | PTGS1 2333/4885GSTK1 3525/4885ALDH1A1 822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.